Target Molecules and their Respective Pathogenic and Protective Antibodies in Myasthenia Gravis.
Recruiting
- Conditions
- Myasthenia Gravis100038161002830210029317
- Registration Number
- NL-OMON36848
- Lead Sponsor
- eurologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
age: 18 years and older
For patients with MG: scheduled for a thymectomie using the Da Vinci Robot
For control patients: scheduled for a thoracic operation using the Da Vinci Robot for a disorder that is not related to an autoimmune disease or disease affecting the muscles
Exclusion Criteria
minors or incapacitated persons
not willing to give informed consent
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The production of 6 monoclonal antibody producing cell lines. The antibodies<br /><br>produced by this cell line will be used for the identification of new<br /><br>autoantigens and the development of new neuroprotective antibodies. </p><br>
- Secondary Outcome Measures
Name Time Method <p>not applicable</p><br>